Generic Vytorin introduced by Teva

Press enter to search
Close search
Open Menu

Generic Vytorin introduced by Teva

By Brian Berk - 04/27/2017

JERUSALEM, Israel — Teva Pharmaceutical Industries launched generic Vytorin (ezetimibe and simvastatin) tablets in the United States. Ezetimibe and simvastatin tablets are a prescription medicine that contains two cholesterol-lowering medicines, ezetimibe and simvastatin, which are used along with diet to lower the level of “bad” cholesterol (low density lipoprotein cholesterol or LDL); increase the level of “good” cholesterol (high density lipoprotein cholesterol or HDL); and lower the level of fat in blood (triglycerides).


Merck’s Vytorin had annual sales of approximately $678 million in the U.S. according to IMS data as of February 2017.   


Related Topics